NEXI - NexImmune Inc - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-2.561M

Cash

4.453M

Avg Qtr Burn

-5.391M

Short % of Float

1.39%

Insider Ownership

17.01%

Institutional Own.

11.17%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
NEXI-002 Details Multiple myeloma, Cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
NEXI-001 Details Myelodysplastic syndrome, Acute myeloid leukemia, Cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.